文献速递血液净化与透析

老年患者对在线血液透析滤过的治疗耐受性和患者报告结局优于高通量血液透析

Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.
PubMed 文献 · Kidney Int · 2017-03-18

FRENCHIE研究是一项前瞻性开放标签随机对照试验,纳入381例65岁以上慢性血液透析患者,按1:1随机分配至高通量血液透析或在线血液透析滤过组。主要终点为透析耐受性(第30天至第120天),两组分别有85%和84%的患者发生至少一次不良事件,无显著差异;探索性分析按实际治疗 sessions 统计,在线血液透析滤过组透析中症状性低血压和肌肉痉挛发作更少。健康相关生活质量、发病率及死亡率两组无差异,在线血液透析滤过组代谢性骨病生物标志物和β2-微球蛋白控制改善,血清白蛋白无变化。

要点

  • 在381例65岁以上慢性血液透析患者中,高通量血液透析组85%与在线血液透析滤过组84%的患者发生至少一次不良事件,无显著差异。
  • 探索性分析按实际治疗 sessions 统计共11981次,2935次发生至少一次不良事件,在线血液透析滤过组症状性低血压和肌肉痉挛发作更少。
  • 在线血液透析滤过组代谢性骨病生物标志物和β2-微球蛋白水平控制改善,血清白蛋白浓度无变化。

核心结论

  • 在老年慢性血液透析患者中,总体结局支持在线血液透析滤过优于高通量血液透析。

研究设计与样本

  • 前瞻性、开放标签随机对照试验,381例65岁以上慢性血液透析患者按1:1随机分配至高通量血液透析或在线血液透析滤过组。

主要发现

  • 透析耐受性观察期(第30天至第120天),高通量血液透析组85%与在线血液透析滤过组84%的患者发生至少一次不良事件,两组无显著差异。
  • 探索性分析按实际治疗 sessions 统计,共11981次 sessions 中2935次发生至少一次不良事件,在线血液透析滤过组症状性低血压和肌肉痉挛发作更少。
  • 健康相关生活质量、发病率及死亡率两组无差异。
  • 在线血液透析滤过组代谢性骨病生物标志物和β2-微球蛋白水平控制改善,血清白蛋白浓度无变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Large cohort studies suggest that high convective volumes associated with online hemodiafiltration may reduce the risk of mortality/morbidity compared to optimal high-flux hemodialysis. By contrast, intradialytic tolerance is not well studied. The aim of the FRENCHIE (French Convective versus Hemodialysis in Elderly) study was to compare high-flux hemodialysis and online hemodiafiltration in terms of intradialytic tolerance. In this prospective, open-label randomized controlled trial, 381 elderly chronic hemodialysis patients (over age 65) were randomly assigned in a one-to-one ratio to either high-flux hemodialysis or online hemodiafiltration. The primary outcome was intradialytic tolerance (day 30-day 120). Secondary outcomes included health-related quality of life, cardiovascular risk biomarkers, morbidity, and mortality. During the observational period for intradialytic tolerance, 85% and 84% of patients in high-flux hemodialysis and online hemodiafiltration arms, respectively, experienced at least one adverse event without significant difference between groups. As exploratory analysis, intradialytic tolerance was also studied, considering the sessions as a statistical unit according to treatment actually received. Over a total of 11,981 sessions, 2,935 were complicated by the occurrence of at least one adverse event, with a significantly lower occurrence in online hemodiafiltration with fewer episodes of intradialytic symptomatic hypotension and muscle cramps. By contrast, health-related quality of life, morbidity, and mortality were not different in both groups. An improvement in the control of metabolic bone disease biomarkers and β2-microglobulin level without change in serum albumin concentration was observed with online hemodiafiltration. Thus, overall outcomes favor online hemodiafiltration over high-flux hemodialysis in the elderly.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Morena M, Jaussent A, Chalabi L, et al. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int. 2017. PMID: 28318624. doi:10.1016/j.kint.2017.01.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。